Alzheimer’s affects over seven million Americans—a number expected to double by 2050. New FDA-approved drugs and early-detection blood tests give families hope, but government red tape still stands in the way. The Market Institute believes patients and doctors—not bureaucrats—should decide when to use lifesaving innovations. Empowering access to modern treatments isn’t just good policy—it’s the compassionate choice.
In a recent column for RealClearMarkets, Market Institute Senior Fellow Norm Singleton warns that Federal Trade Commission (FTC) Chair Andrew Ferguson is stretching consumer protection law into dangerous territory—one that risks colliding directly with the Read more…
In a recent column published in RealClearMarkets, Market Institute President Charles Sauer explains how Walmart’s rise to a trillion-dollar company illustrates the power of free markets—and why policymakers should rethink modern antitrust enforcement. Walmart recently Read more…
In a new RealClearMarkets article, Market Institute President Charles Sauer warns that Washington’s instinct to “do something” after a tragedy often leads to bad policy that expands government power without addressing the real causes of Read more…
The European Union has long been a source of both classical liberal ideas and expansive government regulation. Today, the EU is increasingly exporting its regulatory model beyond its borders—including policies that threaten free speech online. Read more…
A new column by The Market Institute President Charles Sauer published in RealClearMarkets examines how outdated tax policy is quietly worsening America’s housing affordability crisis — and how a simple reform could help free up Read more…
The Market Institute and the Center for a Free Economy (CFE) led a coalition of free-market leaders and organizations urging congressional leadership to pass the More Homes on the Market Act (H.R. 1340 / S. Read more…
6151 Fuller Court #8
Alexandria, VA 22310
The Market Institute
info@marketinstitute.org